The University of Chicago Header Logo

Connection

James Vardiman to Topotecan

Back to Details
This is a "connection" page, showing publications James Vardiman has written about Topotecan.
James Vardiman
Connection Strength
0.082
Topotecan
  1. Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803). Cancer. 2009 Jan 01; 115(1):84-93.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.